Oliver M Schleicher

ORCID: 0009-0007-5939-7742 · 2 papers in corpus

2026

Histological evaluation of hysterectomy specimens after NovaSure® endometrial ablation in patients with atypical endometrial hyperplasia or endometrial carcinoma.

Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08497-x

BackgroundTreatment with NovaSure® endometrial ablation is approved for patients with heavy menstrual bleeding (HMB) without evidence of malignant or premalignant lesions. This analysis addresses the rare but clinically relevant situation i…

article 2026

Retrospective analysis of outcome after endometrial ablation with the NovaSure device: A German single-center experience

International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.71224

OBJECTIVE: Evaluation of retrospective outcomes of NovaSure treatment in patients with abnormal uterine bleeding, including safety and cost-effectiveness, and risk factors related to therapeutic outcomes. Subgroup analysis was conducted for…